• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® HYBRID VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® HYBRID VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number 0650HYB0805
Device Problem Insufficient Information (3190)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 04/17/2015
Event Type  Injury  
Manufacturer Narrative
Date when partial infarction of the respective kidney segment was observed remains unknown.Therefore date when literature article was accepted will be taken as event date.The review of the manufacturing records verified that this lot met all pre-release specifications.(b)(4).W.L.Gore & associates received two lot numbers which were implanted during the procedure (lot # 10109675 and lot # 10120460).According to the physician it is unclear which lot covered a side branch of the renal artery.Therefore gore is submitting a report for each lot reported.
 
Event Description
During an article review, with the title "results of the gore® hybrid vascular graft in challenging aortic branch revascularization during complex aneurysm repair", published in the journal annals of vascular surgery in 2015 from nikolaos tsilimparis, md et all, following was noted: a retrospective analysis of 12 patients treated with the gore® hybrid vascular graft was performed.Indication for gore® hybrid vascular graft implantation included difficult access to target vessel and surgeon's decision to reduce organ ischemia time during revascularization.The procedures in which the gore® hybrid vascular graft was considered were visceral debranching procedures prior to thoracoabdominal stent-grafting, as well as challenging revascularization of renal and hypogastric arteries.Within a 26-month period 25 gore® hybrid grafts were implanted in 12 patients.Technical success was achieved in all cases.Beside this information, following was reported: in one case, a side branch of the renal artery perfusing a third of the ipsilateral kidney was covered with the stent graft of the gore® hybrid vascular graft, thus resulting in partial infarction of the respective kidney segment without relevant worsening of renal function.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® HYBRID VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5266651
MDR Text Key32680291
Report Number2017233-2015-00855
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K093934
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 11/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/06/2014
Device Catalogue Number0650HYB0805
Device Lot Number10120460
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/04/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/09/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age33 YR
-
-